Production of recombinant proteins including the B-cell epitopes of autolysin A of Staphylococcus aureus isolated from clinical sheep mastitis and their potential for vaccine development.

Autor: Azara E; Istituto Zooprofilattico Sperimentale della Sardegna 'G. Pegreffi', Sassari, 07100, Italy., Foddai AC; School of Biological Sciences, University of Aberdeen, Aberdeen, Scotland., Longheu CM; Istituto Zooprofilattico Sperimentale della Sardegna 'G. Pegreffi', Sassari, 07100, Italy., Addis MF; Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, Lodi, 26900, Italy. Filippa.addis@unimi.it.; Laboratorio di Malattie Infettive degli Animali (MiLab), Università degli Studi di Milano, Lodi, 26900, Italy. Filippa.addis@unimi.it., Tola S; Istituto Zooprofilattico Sperimentale della Sardegna 'G. Pegreffi', Sassari, 07100, Italy. sebastiana.tola@izs-sardegna.it.
Jazyk: angličtina
Zdroj: Veterinary research communications [Vet Res Commun] 2023 Sep; Vol. 47 (3), pp. 1665-1674. Date of Electronic Publication: 2023 Apr 19.
DOI: 10.1007/s11259-023-10121-1
Abstrakt: Staphylococcus aureus is the most common clinical mastitis-associated pathogen in sheep which contributes to reduced welfare of affected animals and, therefore, compromises the quality and quantity of milk production. To prevent mastitis and its spread, it is essential to guarantee adequate breeding conditions and animal health, through the adoption of good farm management practices and the application of suitable biosecurity measures. Vaccination can play a strategic role in prevention, control, and eradication of diseases. The identification of secreted and cellular antigens of the predominant sheep-CC130/ST700/t1773 lineage would assist in the design of effective vaccine against mammary infections caused by S. aureus. In the current study, we carried out a 3D structural prediction analysis with the identification of the best B cell epitopes of the whole and secreted portion of S. aureus AtlA. Fragments of atlA, containing the main predicted epitopes, were amplified, cloned, and expressed in Escherichia coli for recombinant protein production. Two selected clones produced recombinant proteins (rAtl4 and rAtl8) showing strong reactivity with a hyperimmune serum against the native AtlA and with blood sera collected from sheep with clinical S. aureus mastitis. These may represent potential candidate protein-based vaccines able to elicit a protective immune response to be evaluated by vaccination and subsequent challenge of the vaccinated sheep.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: